Cardiometabolic & kidneyGuideline or statement
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- Clinical practice guideline
Literature search October 29, 2024, to April 14, 2025 (MEDLINE, EMBASE, Cochrane Library, AHRQ, others); human studies published since 2015 in English
Scope
As issued by the authors
Prevention, detection, evaluation and management of cardiovascular-kidney-metabolic syndrome (metabolic risk factors incl. obesity and T2DM, CKD, CVD); retires and replaces the 2013 AHA/ACC/TOS obesity guideline
Original publication
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. Published 9 June 2026. doi:10.1161/cir.0000000000001453
Summarised from the published abstract; every number is checked against it